298 related articles for article (PubMed ID: 18505172)
1. Should treatment of hepatitis B depend on hepatitis B virus genotypes? A hypothesis generated from an explorative analysis of published evidence.
Wiegand J; Hasenclever D; Tillmann HL
Antivir Ther; 2008; 13(2):211-20. PubMed ID: 18505172
[TBL] [Abstract][Full Text] [Related]
2. Response to antiviral treatment in patients infected with hepatitis B virus genotypes E-H.
Erhardt A; Göbel T; Ludwig A; Lau GK; Marcellin P; van Bömmel F; Heinzel-Pleines U; Adams O; Häussinger D
J Med Virol; 2009 Oct; 81(10):1716-20. PubMed ID: 19697400
[TBL] [Abstract][Full Text] [Related]
3. Treatment of chronic hepatitis B virus infection - Dutch national guidelines.
Buster EH; van Erpecum KJ; Schalm SW; Zaaijer HL; Brouwer JT; Gelderblom HC; de Knegt RJ; Minke Bakker C; Reesink HW; Janssen HL;
Neth J Med; 2008; 66(7):292-306. PubMed ID: 18663260
[TBL] [Abstract][Full Text] [Related]
4. Response to long-term lamivudine treatment in patients infected with hepatitis B virus genotypes A, B, and C.
Kobayashi M; Suzuki F; Akuta N; Suzuki Y; Arase Y; Ikeda K; Hosaka T; Sezaki H; Kobayashi M; Iwasaki S; Sato J; Watahiki S; Miyakawa Y; Kumada H
J Med Virol; 2006 Oct; 78(10):1276-83. PubMed ID: 16927289
[TBL] [Abstract][Full Text] [Related]
5. Persistence of acute infection with hepatitis B virus genotype A and treatment in Japan.
Suzuki Y; Kobayashi M; Ikeda K; Suzuki F; Arfase Y; Akuta N; Hosaka T; Saitoh S; Kobayashi M; Someya T; Matsuda M; Sato J; Watabiki S; Miyakawa Y; Kumada H
J Med Virol; 2005 May; 76(1):33-9. PubMed ID: 15779048
[TBL] [Abstract][Full Text] [Related]
6. [Relationship between B virus hepatitis genotypes and therapeutic efficacy in early treatment for chronic hepatitis B by using lamivudine].
Song SJ; Zhuang H; Yan J; Wei HS; He ZP; Song C; Dong QM; Xiao YP
Zhonghua Yu Fang Yi Xue Za Zhi; 2005 May; 39(3):203-5. PubMed ID: 15938857
[TBL] [Abstract][Full Text] [Related]
7. Frequent detection of hepatitis B virus variants associated with lamivudine resistance in treated South African patients infected chronically with different HBV genotypes.
Selabe SG; Song E; Burnett RJ; Mphahlele MJ
J Med Virol; 2009 Jun; 81(6):996-1001. PubMed ID: 19382250
[TBL] [Abstract][Full Text] [Related]
8. Analysis of hepatitis B virus genotypes and pre-core region variability during interferon treatment of HBe antigen negative chronic hepatitis B.
Zhang X; Zoulim F; Habersetzer F; Xiong S; Trépo C
J Med Virol; 1996 Jan; 48(1):8-16. PubMed ID: 8825704
[TBL] [Abstract][Full Text] [Related]
9. Hepatitis B virus genotypes B and C do not affect the antiviral response to lamivudine.
Yuen MF; Wong DK; Sablon E; Yuan HJ; Sum SM; Hui CK; Chan AO; Wang BC; Lai CL
Antivir Ther; 2003 Dec; 8(6):531-4. PubMed ID: 14760886
[TBL] [Abstract][Full Text] [Related]
10. Long-term follow-up of lamivudine treatment in patients with severe acute exacerbation of hepatitis B e antigen (HBeAg)-positive chronic hepatitis B.
Wong VW; Wong GL; Tsang SW; Hui AY; Chim AM; Yiu KK; Chan HY; Chan FK; Sung JJ; Chan HL
Antivir Ther; 2008; 13(4):571-9. PubMed ID: 18672536
[TBL] [Abstract][Full Text] [Related]
11. [Genotyping of hepatitis B virus and clinical investigation].
Wang Y; Zhou G; Li X; Zhou Z; Zhou S; Ruan L; Chen M; Deng W
Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi; 2002 Dec; 16(4):367-9. PubMed ID: 12665908
[TBL] [Abstract][Full Text] [Related]
12. Therapeutic implications of hepatitis B virus genotypes.
Liu CJ; Kao JH; Chen DS
Liver Int; 2005 Dec; 25(6):1097-107. PubMed ID: 16343058
[TBL] [Abstract][Full Text] [Related]
13. No benefit to continue lamivudine therapy after emergence of YMDD mutations.
Liaw YF; Chien RN; Yeh CT
Antivir Ther; 2004 Apr; 9(2):257-62. PubMed ID: 15134188
[TBL] [Abstract][Full Text] [Related]
14. Genetic characteristics of hepatitis B virus genotypes as a factor for interferon-induced HBeAg clearance.
Hou J; Schilling R; Janssen HL; Hansen BE; Heijtink R; Sablon E; Williams R; Lau GK; Schalm SW; Naoumov NV
J Med Virol; 2007 Aug; 79(8):1055-63. PubMed ID: 17596838
[TBL] [Abstract][Full Text] [Related]
15. Treatment of HBeAg-positive patients with nucleos/tide analogues.
Coffin CS; Lee SS
Liver Int; 2009 Jan; 29 Suppl 1():116-24. PubMed ID: 19207974
[TBL] [Abstract][Full Text] [Related]
16. Potential and limitations of lamivudine monotherapy in chronic hepatitis B: evidence from genotyping.
Kennedy PT; Phillips N; Chandrasekhar J; Jacobs R; Jacobs M; Dusheiko G
Liver Int; 2008 May; 28(5):699-704. PubMed ID: 18433396
[TBL] [Abstract][Full Text] [Related]
17. YMDD mutations and genotypes of hepatitis B virus in northern China.
Li D; Gu HX; Zhang SY; Zhong ZH; Zhuang M; Hattori T
Jpn J Infect Dis; 2006 Feb; 59(1):42-5. PubMed ID: 16495633
[TBL] [Abstract][Full Text] [Related]
18. Viral genotypes and response to interferon in patients with acute prolonged hepatitis B virus infection of adulthood in Japan.
Kobayashi M; Arase Y; Ikeda K; Tsubota A; Suzuki Y; Saitoh S; Kobayashi M; Suzuki F; Akuta N; Someya T; Matsuda M; Sato J; Takagi K; Miyakawa Y; Kumada H
J Med Virol; 2002 Dec; 68(4):522-8. PubMed ID: 12376960
[TBL] [Abstract][Full Text] [Related]
19. Combined interferon plus lamivudine treatment in young patients with dual HBV (HBeAg positive) and HCV chronic infection.
Marrone A; Zampino R; D'Onofrio M; Ricciotti R; Ruggiero G; Utili R
J Hepatol; 2004 Dec; 41(6):1064-5. PubMed ID: 15582146
[No Abstract] [Full Text] [Related]
20. Difference in T helper responses during hepatitis flares in hepatitis B e antigen (HBeAg)-positive patients with genotypes B and C: implication for early HBeAg seroconversion.
Yuen MF; Wong DK; Zheng BJ; Chan CC; Yuen JC; Wong BC; Lai CL
J Viral Hepat; 2007 Apr; 14(4):269-75. PubMed ID: 17381719
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]